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The peptide pVEC is a recently described cell-penetrating peptide, derived from the murine vascular endothelial-cadherin protein. In order to
define which part of this 18-amino acid long peptide is important for the cellular translocation, we performed a structure–activity relationship
study of pVEC. Together with the L-alanine substituted peptides, the retro-pVEC, D-pVEC and the scramble pVEC are studied for comparison.
The peptide analogues are labeled with carboxyfluorescein at the N-terminus for monitoring the cellular uptake into human Bowes melanoma cells
with different efficacy. We show that all the Fl-pVEC analogues internalize in live Bowes melanoma cells. L-Alanine substitution of the five
respective N-terminal hydrophobic amino acids significantly decreases the translocation property, while replacing of Arg6, Arg8 or Ser17 by
alanine enhances the uptake. The uptake of pVEC is significantly reduced by treatment with an endocytosis inhibitor wortmannin. Treatment with
heparinase III, nystatin and EIPA had no effect on the peptide uptake. The data presented here show that the N-terminal hydrophobic part of pVEC
is crucial for efficient cellular translocation.
© 2006 Elsevier B.V. All rights reserved.Keywords: pVEC; Cell-penetrating peptide; VE-cadherin; Cellular uptake; L-Ala-scan, S.A.R study1. Introduction
The main field of application for cell-penetrating peptides
(CPPs) is the delivery of hydrophilic compounds to the cell
interior [1,2]. The 18-amino acid-long peptide pVEC has
previously been shown to be able to internalize into several cell
lines in vitro [3]. pVEC is derived from the murine vascular
endothelial-cadherin (VE-cadherin) protein which main func-
tion is to mediate physical contact between adjacent cells by
homophilic dimerization. VE-cadherin also plays an active role
in transferring information from the outside of the cell and for
the control of vascular permeability and angiogenesis. Four ArgAbbreviations: BMC, Bowes melanoma cells; CPP, cell-penetrating peptide;
D-pVEC, ent-pVEC (all-D-enantiomer of pVEC); EIPA, 5-(N-ethyl-N-isopro-
pyl)-amiloride; Fl, 5-(and-6) carboxyfluoresceinyl; HKR, HEPES-buffered
Krebs–Ringer solution; LDH, lactate dehydrogenase; MALDI-TOF, matrix-
assisted laser desorption ionization time-of-flight; PI3K, phosphatidylinositol-3-
OH kinase; pVEC, peptide vascular endothelial-cadherin; RP HPLC, reverse-
phase HPLC; S.A.R., structure–activity relationship; VE-cadherin, vascular
endothelial-cadherin
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doi:10.1016/j.bbamem.2006.05.013and two Lys residues in the primary sequence make pVEC
highly positively charged when diluted in physiological buffer.
Recently, we showed that the basic amino acids, besides adding
positive charges to the peptide, make pVEC susceptible to
protease degradation [4]. In general, the N-terminus of the
pVEC sequence is hydrophobic, the middle part charged and the
C-terminus hydrophilic. In previous cargo-delivery experi-
ments, pVEC was able to carry the proteins avidin [5] and
streptavidin [3] and a hexameric PNA oligomer into cells [3].
Further, pVEC uptake into several microbial species including
gram-negative bacteria, gram-positive bacteria and fungi has
been shown together with preferential killing of microbes over
eukaryotic cells [6].
The uptake mechanism(s) for cell-penetrating peptides have
been investigated over the years. At first, a temperature- and
receptor independent uptake pathway was reported for several
CPPs. Recent data have, however, revealed a possible common
endocytotic internalization mechanism among arginine-rich basic
peptides such as poly-Arg, Tat (48–60) and penetratin [7,8].
Here, we carried out a structure–activity relationship (S.A.R.)
study of the pVEC sequence to define the importance of each
residue and the effect of a single substitution on the translocation
ability. The amino acids were one by one substituted with L-Ala,
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Ala (Table 1), and the internalization of the fluoresceinyl
derivatives was studied in live human Bowes melanoma cells.
Additionally, we included the D-enantiomer of pVEC (D-pVEC),
consisting only of the D-amino acids, the retro-pVEC, with
reversed primary sequence, and the scramble pVEC peptide
(Table 1) to the study. The cellular uptake of the Fl-pVEC
analogues was quantified in Bowes melanoma cells. The pVEC
and D-pVEC cellular uptake was further quantified in cells, pre-
treated with known endocytotic inhibitors: wortmannin, nysta-
tin, heparinase III or EIPA. In addition colocalization with
tetramethylrodamine (TAMRA) labeled transferrin as a marker
of endocytosis was performed, to confirm the quantification
studies. The peptide uptake at low temperature was quantified
for pVEC and D-pVEC. The effect of the peptides on cellular
toxicity was measured by determining the release of lactate
dehydrogenase (LDH).2. Materials and methods
2.1. Peptide synthesis and labeling
The peptides (Table 1) were separately synthesized in a stepwise manner in
a 0.1 mmol scale on a peptide synthesizer (Applied Biosystems model 431A,
USA) using t-Boc strategy of solid-phase peptide synthesis. tert-Butylox-
ycarbonyl amino acids were coupled as hydroxybenzotriazole esters to a p-
methylbenzylhydrylamine resin (Neosystem, Strasbourg, France) to obtain
C-terminally amidated peptides. The peptides were labeled with 5-(and-6)-
carboxyfluorescein succinimidyl ester (Molecular Probes, Leiden, Netherlands)
at the N-terminus as described previously [3]. Deprotection of the
dinitrophenol group was carried out by treatment with 20% thiophenol in
DMF for 1 h at room temperature. The peptides were finally cleaved from the
solid phase with liquid HF at 0 °C for 1 h in the presence of p-cresol.Table 1
Properties of pVEC analogues
Sequence Name Molec
LLIILRRRIRKQAHAHSK pVEC 2208.7
ALIILRRRIRKQAHAHSK [Ala1]pVEC 2166.7
LAIILRRRIRKQAHAHSK [Ala2]pVEC 2166.7
LLAILRRRIRKQAHAHSK [Ala3]pVEC 2166.7
LLIALRRRIRKQAHAHSK [Ala4]pVEC 2166.7
LLIIARRRIRKQAHAHSK [Ala5]pVEC 2166.7
LLIILARRIRKQAHAHSK [Ala6]pVEC 2123.6
LLIILRARIRKQAHAHSK [Ala7]pVEC 2123.6
LLIILRRAIRKQAHAHSK [Ala8]pVEC 2123.6
LLIILRRRARKQAHAHSK [Ala9]pVEC 2123.6
LLIILRRRIAKQAHAHSK [Ala10]pVEC 2123.6
LLIILRRRIRAQAHAHSK [Ala11]pVEC 2151.6
LLIILRRRIRKAAHAHSK [Ala12]pVEC 2151.7
LLIILRRRIRKQAHAHSK [D-Ala13]pVEC 2208.7
LLIILRRRIRKQAAAHSK [Ala14]pVEC 2142.7
LLIILRRRIRKQAHAHSK [D-Ala15]pVEC 2208.7
LLIILRRRIRKQAHAASK [Ala16]pVEC 2142.7
LLIILRRRIRKQAHAHAK [Ala17]pVEC 2192.7
LLIILRRRIRKQAHAHSA [Ala18]pVEC 2151.6
KSHAHAQKRIRRRLIILL retro-pVEC 2208.7
LLIILRRRIRKQAHAHSK D-pVEC 2208.7
IAARIKLRSRQHIKLRHL scramble pVEC 2208.7
All sequences listed, were C-terminally amidated. Molecular masses are given as calc
Number of positive charges is given at physiological pH, together with N- and C-te2.2. HPLC purification and analysis
Purification of peptides with reverse-phase (RP) HPLC was carried out with
a Supelcosil LC-18 preparative column (25 cm×21.2 mm, 5 μm) (Sigma
Aldrich Chemie, Steinheim, Germany) using water–acetonitrile, both contain-
ing 0.1% CF3COOH, gradient from 20 to 100%. The purity of the peptides was
>95%, according to HPLC analysis performed as described below. Correct
molecular masses of purified peptides were obtained by using MALDI-TOF
(Voyager-DE STR, Applied Biosystems) mass spectrometer.
The purity and retention times of Fl-peptides (Table 1) were determined
using Dionex P680 HPLC gradient system (Idstein, Germany ) with Discovery
BIO Wide pore C18 RP column (150×4.6 mm) (Sigma Aldrich Chemie,
Steinheim, Germany) and Dionex RF2000 fluorescence HPLC monitor (Idstein,
Germany). 100 μl of Fl-peptide solution in water was subjected to HPLC
analysis. The elution was carried out with water (A) and acetonitrile (B), both
containing 0.1% CF3COOH, at a flow rate 1.0 ml/min with gradient of 20–
100% B (1–21 min). Fluorescence at 520 nm was recorded after excitation at
445 nm. Average of at least two separate measurements was taken as a retention
time with error limits of one standard deviation.
2.3. Cell culture
Human Bowes melanoma cells (BMC, American Type Culture Collection
CRL-9607) were cultivated in Minimal Essential Medium (MEM) with
glutamax, supplemented with 10% foetal bovine serum, 1% penicillin-
streptomycin solution, 1% non-essential amino acids and 1% sodium pyruvate.
2.4. Qualitative cellular uptake of fluoresceinyl-peptides
2.4.1. Fluorescence microscopy
Bowes melanoma cells were seeded at the density of 20 000 cells per well on
round glass coverslips in 24-well-plate. One day post-seeding, the culturing
media was exchanged into serum-free (SF) media and 10 μM of Fl-peptide was
added. In some experiments 50 nM of wortmannin or 50 μg/ml of nystatin were
added 30 min prior to adding the peptide. After 1 h of incubation at 37 °C, cells
were treated with 0.05% trypsin for 3 min and washed twice with PBS.
Coverslips were mounted using Vectashield mounting media (Vectorular mass (Da) Rt (min±S.D.) Positive charges
22.1±0.2 7
21.1±0.9 7
20.9±0.2 7
21.5±0.3 7
21.7±0.2 7
21.9±1.4 7
23.0±0.4 6
22.0±0.7 6
25.5±0.2 6
21.5±0.8 7
16.3±0.9 6
22.3±0.2 6
21.9±0.2 7
21.6±0.1 7
21.6±0.5 7
16.4±0.0 7
22.4±1.0 7
18.5±3.2 7
17.6±1.3 6
16.5±4.4 7
16.6±0.0 7
10.2±0.01 7
ulated for unlabeled peptides. Retention times (Rt) are obtained for Fl-peptides.
rminal charges.
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IRE2 fluorescence microscope at 63 times magnification (Leica Microsystems,
Stockholm, Sweden) and processed in Photoshop 7.0 software (Adobe Systems
Inc, Ca, and USA).
2.4.2. Confocal LASER scanning microscopy
Bowes melanoma cells were seeded at the density of 50,000 cells per well in
8-well chambered coverglasses (Nalge Nunc International, Rochester, NY).
Experiment was the conducted as described above, except that cells were co-
incubated with 10 μM of Fl-peptide and 50 ng/ml of TAMRA-transferrin in SF
media. After 1 h incubation at 37 °C the media with the complexes was
removed, the cells were rinsed twice with PBS, covered with PBS and the serial
images were recorded using the laser confocal scanning microscope Zeiss
Axiovert 200 (Carl Zeiss, Göttingen, Germany), equipped with PerkinElmer
Ultra-View ERS Rapid Confocal Imager (PerkinElmer Ltd., Beaconsfield, UK).
2.5. Quantitative cellular uptake of fluoresceinyl-peptides
Cells were seeded in 6-well plates at the density of 3×105 cells / well. After
72 h, the cells were washed once with SF media and treated with 10 μM of Fl-
peptide in SF media for 1 h at 37 °C. After the incubation, the cells were washed
once with trypsin (0.25%), twice with HKR buffer and lysed with 400 μl of
0.1 M NaOH for 10 min at room temperature. The cell lysates were centrifuged
(14 000×g for 5 min) and the fluorescence intensity of the supernatant (100 μl)
measured at 494/518 nm in a Spectramax Gemini XS plate-reader (Molecular
Devices, USA). The peptide concentration was calculated from a standard curve
of the respective peptide in 0.1 M NaOH. The cellular protein content was
determined by the method of Lowry [9] using a Sigma-Aldrich protein assay kit
(Sigma-Aldrich, Sweden) with bovine serum albumin (BSA) as standard. The
cellular uptake of pVEC and its analogues is expressed as picomole peptide per
mg of total cellular protein.
To investigate the endocytotic component in the uptake, cells were treated
with wortmannin (50 nM), nystatin (50 μg/ml), heparinase III (0.5 units/well)
(E.C. 4.2.2.8) or EIPA (50 μM) (all from Sigma-Aldrich, Sweden). The
pretreatment was conducted in serum-free (SF) MEM at 37 °C for 30 min,
except for the nystatin treatment, which was in HKR supplemented with 0.2%
BSA. After 30 min, the heparinase treated cells were rinsed with SF media and
then incubated with SF media containing 10 μM of Fl-peptide, added directly to
the wortmannin, nystatin and EIPA treated cells. The experiment was then
conducted as described above.
2.6. Lactate dehydrogenase release assay
To assess the possible impairment of the cellular plasma membranes
during peptide passage, the lactate dehydrogenase (LDH) release assay [10]
was performed by using a CytoTox-ONE™ membrane integrity assay kit
(Promega), according to the instructions of the manufacturer of the kit. BMC
were seeded at a density of 100,000 cells/well in 24-well plates. One day post-
seeding, the cells were rinsed with SF media and incubated with SF mediaFig. 1. Quantitative uptake of Fl-pVEC analogues in BMC. The cells were treated with
were washed once with trypsin, twice with HKR buffer and lysed with 0.1 MNaOH. T
supernatant and calculated from a standard curve of the respective peptide. The cellul
total cellular protein. Results are expressed as mean±S.E.M. from three indepen
**P<0.01; ***P<0.001 (two-way ANOVA followed by Bonferroni post-test) signicontaining 10 μM of Fl-peptide. The plate was incubated at 37 °C and 300
rpm in a thermo mixer for 10 min. Background value is obtained from
untreated cells and maximum LDH release by treating cells with 0.18% Triton
X-100. 100 μl of the cell media was transferred to a black 96-well-plate and
100 μl of the substrate mix was added to each well. After 10 min of incubation at
room temperature, the enzymatic reaction was stopped and the fluorescence
measured at 560/590 nm in a Spectramax Gemini XS plate-reader (Molecular
Devices, USA). The cell toxicity is calculated as: % toxicity=100×((experi-
mental-background) / (maximum-background)).3. Results
3.1. Quantification of the cellular peptide uptake
Fl-derivatives of pVEC were used to quantify the cellular
uptake in Bowes melanoma cells after 1 h incubation with
10 μM of peptide at 37 °C.
By substituting any of the five hydrophobic amino acids in the
N-terminus to L-alanine the cellular uptake dropped significantly
with between 50 and 75% compared to the original pVEC
sequence (Fig. 1). A significant reduction in fluorescencewas also
detected when substituting the Ile9 or His14 to L-Ala or when
applying a retro-pVEC. The least efficient uptakewas detected for
scrambled sequence, where the N-terminal hydrophobic residues
are randomly placed into the sequence (Table 1, Fig. 1). In
contrast, an increase in cellular uptake was shown when changing
the Arg6, Arg8 or Ser17 to L-Ala.
Together our data suggest that the hydrophobic N-terminus is
important for peptide uptake, while the rest of the pVEC
sequence can be modestly changed without impairing the
translocation efficacy.
3.2. Effect of endocytosis inhibitors on the pVEC uptake
To investigate the role of endocytosis in the uptake of pVEC,
we treated the BMC with various endocytosis inhibitors. Cells
were treated with wortmannin (50 nM), nystatin (50 μg/ml),
heparinase III (0.5 units/ml) or EIPA (50 μM) in serum-free
media before incubation with Fl-pVEC or Fl-D-pVEC. The
uptake of both peptides was then quantified as described above
in Materials and methods. Wortmannin is known to affect the
fusion of early endosomes by inhibiting the phosphatidylinosi-
tol-3-OH kinase (PI3K) [11], nystatin to inhibit caveolae10 μM of Fl-peptide in SF media for 1 h at 37 °C. After the incubation, the cells
he peptide uptake was determined by measuring the fluorescence intensity of the
ar uptake of pVEC and its analogues is expressed as picomole peptide per mg of
dent experiments where each value was determined in duplicates. *P<0.05;
ficantly different from pVEC.
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membrane [12,13], heparinase III to enzymatically cleave cell
surface sulfated polysaccharides [14] and EIPA to disturb
endocytosis via macropinocytosis [15].
Here, wortmannin decreased pVEC uptake significantly, by
25%, revealing an endocytotic component of the peptide uptake
mechanism (Fig. 2). Treatment with nystatin, heparinase III or
EIPA did not affect the pVEC uptake to the same extent.
Further, none of the four reagents significantly affected the
cellular uptake of D-pVEC.
3.3. Fluorescence microscopy of peptide uptake
Cells were incubated with 10 μM of the respective peptide at
37 °C for 1 h in serum-free media, followed by treatment with
trypsin, to digest the extracellularly bound peptide. All the
peptides tested were internalized into live BMC. L-Ala
substitutions in the N-terminal hydrophobic domain obviously
hindered the uptake, while substitutions in charged or C-terminal
region did not visibly affect the uptake or even increased it. Live
cell images in Fig. 3 represent L-Ala substitutions in the N-
terminal domain—[Ala1] pVEC, middle region—[Ala6] pVEC
and C-terminus—[Ala18] pVEC.
To further investigate the role of hydrophobic domain in
the uptake of pVEC, we introduced two additional
sequences; one shortened N-terminally by 3 amino acids
and another where entire hydrophobic domain was replaced
by L-alanine. Deletion of 3 hydrophobic residues completely
abolished uptake (Fig. 5d). Also, when all 5 hydrophobic
residues were replaced by L-alanines in the N-terminus, the
uptake of peptide was not detected (Fig. 5g).
To confirm the data from the experiment of endocytosis
inhibitors effect on the uptake of pVEC we treated Bowes
melanoma cells with endocytosis inhibitors 50 nM wortmannin
(W) and 50 μg/ml nystatin (N), for 30 min prior the treatment
with peptides and examined the cells by fluorescence micros-Fig. 2. Quantitative uptake of Fl-pVEC and Fl-D-pVEC in BMC pretreated with
endocytosis inhibitors. BMCwere treatedwith 50 nMwortmannin (W), 50μg/ml
nystatin (N), 0.5 units/ml heparinase III (H) or 50 μM EIPA (E). Thereafter,
10 μMof Fl-pVEC (solid bars) or Fl-D-pVEC (open bars) was added in SFmedia
for 1 h at 37 °C. After the incubation, the cells were washed once with trypsin,
twice with HKR buffer and lysed with 0.1 M NaOH. The peptide uptake was
determined by measuring the fluorescence intensity of the supernatant and
calculated from a standard curve of the respective peptide. The cellular uptake is
expressed as percentage of uptake compared to untreated cells (control). Results
are expressed as mean±S.E.M. from three independent experiments where each
value was determined in duplicates. *P<0.05; (two-way ANOVA followed by
Bonferroni post-test) significantly different from pVEC or D-pVEC uptake in
untreated control cells.copy (Fig. 3). No difference was detected with microscopy in the
uptake of Fl-pVEC analogues when treated with different
endocytosis inhibitors.
To further confirm the involvement of endocytotic compo-
nent, the colocalization with transferrin was conducted using
Confocal LASER Scanning Microscopy. In our experiments
little colocalization with Fluorescein-labeled pVEC and
TAMRA-labeled transferrin was detected, confirming the results
obtained from uptake quantification experiments (Fig. 6).
3.4. Temperature effect on cellular uptake
Several investigators have shown that endocytosis has a
threshold temperature of 10 °C [18,19]. Thus, the incubation of
cells at temperatures lower than threshold temperature is an
effective method to investigate the role of endocytosis.
Previously we have shown pVEC uptake at low temperature
with fluorescence microscopy on fixed cells [3]. Here we
quantified the uptake of pVEC and D-pVEC into live BMC at
low temperature (+8 °C) by using the assay described above,
which was not carried out in the previous pVEC studies. BMC
were incubated with 10 μM of pVEC or D-pVEC at 37 °C or
8 °C to examine the temperature dependency of the peptide
uptake. We did not detect any significant change in peptide
uptake when lowering the incubation temperature to +8 °C
(Fig. 4), which correlates well with previous observations.
3.5. Peptide toxicity
The differences recorded in cellular uptake of the pVEC
analogues might be caused by impairment of the cell
membranes that would cause a higher leakage and not a higher
peptide uptake. Therefore peptide toxicity was detected by a cell
leakage assay, which measures the release of lactate dehydro-
genase (LDH) from cells. BMC were treated with the respective
Fl-peptide (10 μM) and the released LDH was measured. None
of the peptides used here caused cell leakage at 10 μM
concentration, when the cells were treated for 10 min at 37 °C
(data not shown).
Prolongation of the incubation time to 1 h did not increase
the LDH leakage. Prolongation of the incubation time also
increases the possibility of LDH breakdown and may, in turn
lead to the underestimation of the toxicity [10]. Our results,
however, show that the registered differences in cellular uptake
are not caused by membrane toxicity.
3.6. Physico-chemical properties of pVEC analogues
The pVEC analogues displayed less than 2 min differences
in RP HPLC retention times, with the exception of the inverted
and the scramble analogues, [Ala10]pVEC and [D-ala15]pVEC
(Table 1), all having significantly shorter retention times.
Interestingly, D-isomer also showed shorter retention time. This
was unexpected, but can be explained with different charge
distribution of those peptides or, in case of [D-Ala15]pVEC,
with conformational change of amino acid side-chain. Much
shorter retention time of D-isomer was also unexpected,
Fig. 3. Internalization of Fl-pVEC analogues into BMC. Cells, attached to the glass coverslips were treated with 10 μMof Fl-peptide in SF media for 1 h at 37 °C. After
the incubation cells were treated with 0.05% trypsin for 3 min, washed twice with PBS buffer and mounted, using Vectashield mounting media. In parallel experiments
nystatin (N) or wortmannin (W) were used to estimate the extent of endocytosis involved in uptake.
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isomer. In general, substitution made in the N-terminal
hydrophobic end of the peptide tends to shorten the retention
time, whereas substitution in the C-terminal part does not affect
the retention time that much.
Substitution of leucine residues in the N-terminal hydrophobic
domain shortened the retention times about 1–2 min, depending
on the residue, whereas replacement of isoleucine residues has less
effect on the retention times. This may indicate that leucineresidues in the N-terminal hydrophobic domain are more
important in forming hydrophobic interactions than isoleucine
residues.
4. Discussion
We have previously reported that pVEC, a peptide derived
from the murine VE-cadherin efficiently translocates into
several cell lines [3]. To evaluate the importance of the
Fig. 4. Quantitative uptake of Fl-pVEC and Fl-D-pVEC in BMC at different
temperatures. The cells were treated with 10 μMof Fl-pVEC (solid bars) or Fl-D-
pVEC (open bars) in SFmedia for 1 h at either 37 °C or 8 °C. After the incubation,
the cells were washed once with trypsin, twice with HKR buffer and lysed with
0.1MNaOH. The peptide uptake was determined by measuring the fluorescence
intensity of the supernatant and calculated from a standard curve of the respective
peptide. The cellular uptake is expressed as picomole peptide per mg of total
cellular protein. Results are expressed as mean±S.E.M. from three independent
experiments where each value was determined in duplicates.
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an L-Ala-scan where each amino acid in pVEC sequence is
replaced, one by one, with L-Ala, except the two original
alanine residues in the sequence that were changed to D-Ala.
The analogues were labeled with fluorescein at the N-terminus
for monitoring the cellular internalization and for quantification
of the uptake in Bowes cells. Together with the L-Ala-analogues
of pVEC, an analogue with the inverted sequence, retro-pVEC,
and the D-pVEC were included in this study. The scrambled
pVEC, which was introduced recently [4], was additionally
included as a negative uptake control.
Previous S.A.R studies have been published for Tat (48–60)
[20] penetratin [21,22] transportan [23,24] and a model
amphipathic peptide [25]. Since these peptides lack the
hydrophobic domains, the studies have mostly shown the
importance of positive charges in cellular uptake. However,
study by Fischer et al. shows also the decreased uptake when
hydrophobic residues are substituted, but this trend is less
pronounced [22].
Even though the representatives of the CPP-family are
largely different in their lengths, charges and structures, some
general conclusions on peptide features can be drawn from the
S.A.R. studies. One is the abundance of multiple positive
charges, especially arginine residues, in the primary peptide
sequence [26,27]. The ability of a peptide to form an
amphipathic helix has also been suggested as key element for
efficient translocation [25].
We used an uptake quantification method where adhered
Bowes melanoma cells are treated with Fl-peptides. The cells
are, after peptide treatment, rinsed thoroughly with buffer
solution and trypsin, lysed with 0.1 M NaOH and the
fluorescence intensity in the cell lysates determined after
centrifugation. The trypsin treatment degrades extracellulary
bound peptide that otherwise could be interpreted as
internalized.
Generally, pVEC consists of a hydrophobic N-terminus, an
arginine-rich middle region and a hydrophilic C-terminus. Our
data show that L-Ala substitution of the five hydrophobic N-terminal residues significantly decreased the cellular uptake.
Prolonging the hydrophobic stretch by changing Arg6 to L-Ala
increased the uptake. A slightly higher uptake was also recorded
when substituting the Ser17 and the Lys18 at the C-terminal of
pVEC. We also quantified the uptake of scramble pVEC, where
the N-terminal hydrophobic domain is broken, but the overall
positive charge of the peptide is not altered (Table 1). The
uptake of scramble pVEC was significantly lower than the
original peptide (Fig. 1). Moreover, when we deleted 3 amino
acids from the N-terminus the uptake of the peptide was
completely abolished (Fig. 5d), also the replacement of the
entire 5 amino acid long hydrophobic domain by alanine
decreased the uptake to undistinguishable from the background
(Fig. 5g). Together these data provide evidence on the
importance of the hydrophobic N-terminal amino acids for
efficient peptide uptake.
Recent studies showed that the uptake of Tat (48–60), (Arg)9
[16] and penetratin [17] was reduced when depleting the cellular
pool of ATP and lowering the temperature, suggesting an
endocytotic uptake component. Wadia and coworkers reported
recently that the uptake of Tat-cre fusion protein takes place
mostly by lipid-raft mediated macropinocytosis [28]. The role
of macropinocytosis was also reported for oligoarginines but
not for penetratin suggesting that different internalization
pathways are used by different arginine-rich CPPs [29].
Wortmannin is an inhibitor of PI3K; an enzyme involved
both in clathrin-dependent endocytosis [11] and macropinocy-
tosis [30]. EIPA, another well-characterized endocytosis
inhibitor specifically affects the macropinocytotic uptake
pathway by inhibiting Na+/H+ exchange protein [15]. In our
experiment 50 nM wortmannin significantly, by about 25%,
lowered the uptake of pVEC into Bowes cells whereas 50 μM
EIPA did not affect the uptake. These results indicate that
clathrin-dependent endocytosis prevails over macropinocytosis
in the pVEC uptake mechanism. Fischer and coworkers
recently reported approximately 50% lower uptake for Fl-
penetratin and Fl-(Arg)9 after treatment with 100 nM wort-
mannin in MC57 cells [8]. Further experiments using
chloroquine and bafilomycin A1, inhibitors of endosomal
acidification and vacuolar H+-ATPases respectively, also
decreased the uptake of peptides suggesting the mechanisms
of clathrin-dependent endocytosis and, further, retrograde
trans-Golgi transport to the ER [8].
Previous report from Suzuki and coworkers shows approx-
imately 7% decreased uptake of 1 μM Fl-Tat (48–60) and Fl-
Arg8 in HeLa cells pretreated with 50 nM wortmannin for
30 min, approximately 3% less uptake was shown when cells
were pretreated with 50 μg/ml nystatin [7]. The minor effect of
wortmannin can be explained with its lower concentration
compared to present work and recently reported [8].
Although the decrease in uptake was significant after
wortmannin treatment, remaining cellular internalization may
indicate the presence of another complementary uptake
mechanism. The translocation of the D-pVEC and the retro-
pVEC shows that no specific receptor is involved in the
uptake process. The significant difference in the uptake of the
latter two, structurally very similar peptides can be explained
Fig. 5. N-terminal modifications abolish peptide internalization. BMC, attached to glass coverslips were treated with 10 μM Fl-pVEC (top), Fl-des-(1–3)pVEC
(middle) or Fl-[Ala1–5]pVEC (bottom row) respectively, in SF media for 1 h at 37 °C. After the incubation cells were treated with 0.05% trypsin for 3 min,
washed twice with PBS buffer and nuclei were stained with fluorescent Hoechst stain. Thereafter the glass coverslips were mounted, using Vectashield mounting
media. Fl-pVEC (A) is internalized into BMC. Deletion of three amino acids from N-terminus completely abolishes the uptake of Fl-labeled peptide (D), as well as
replacement of entire N-terminal hydrophobic domain by alanine residues (G). B, E, H—nuclear staining with Hoechst stain. C, F, I—merged images of fluorescein
and Hoechst.
727A. Elmquist et al. / Biochimica et Biophysica Acta 1758 (2006) 721–729with the resistance to the trypsin degradation of the D-pVEC
prior measuring the uptake. Removal of cell-surface proteo-
glycans with heparinase III, which otherwise could explain
the uptake of both D- and L-enantiomers as well as peptides
with inversed sequences, did not alter the internalization of
pVEC nor its D-enantiomer. Endocytotic processes are consid-
ered to be halted at temperatures below +10 °C as the flexibilityFig. 6. Colocalization of Fl-pVEC and TMR-transferrin. BMC were coincubated wit
37 °C. Thereafter cells were rinsed twice with PBS, covered with PBS and submitted t
shows relatively modest colocalization of pVEC and transferrin.of plasma membrane is drastically reduced [18,19]. However,
substrate binding to the membranes still takes place at lower
temperatures; therefore the trypsin treatment in order to remove
membrane bound peptide is essential when investigating
internalization of a CPP at low temperature. In our experiment
the uptake of pVEC at +8 °Cwas not reduced, further confirming
the presence of non-endocytic uptake mechanism (Fig. 6).h 10 μM Fl-pVEC (A) and 50 μg/ml TMR-transferrin (B) in SF media for 1 h at
o confocal microscopy, as described inMaterials and methods. Merged image (C)
728 A. Elmquist et al. / Biochimica et Biophysica Acta 1758 (2006) 721–729In the light of our current data it seems likely, that pVEC due
to its partial transmembrane origin [3] has some kind of direct
interaction with plasma membrane through the N-terminal
hydrophobic stretch. Most likely this part inserts to the plasma
membrane and this allows the cargo/marker to internalize. This
would explain the equal internalization of both L- and D-isomers
and the reversed sequence. This type of membrane insertion can
also explain the very low toxicity of pVEC even at relatively
high concentrations (10 μM).
On the other hand, scramble pVEC does not have
hydrophobic domain in its N-terminus (Table 1), hence it is
logical to see the decreased uptake. Additionally, the removal of
3 hydrophobic amino acids abolished the uptake.
The potential limitations of using high concentrations of
peptides are their possible effects on the composition of plasma
membrane. Massive binding of hydrophobic peptide to the
membrane may potentially lead to the disturbance in the
coordination of membrane lipids, which in turn may lead to the
increase in peptide internalization. However, this kind of
disturbance would probably also lead to the increased cellular
toxicity and could be detected as leakage of LDH. Since in
present study, 10 μM peptide concentration showed no leakage
of LDH after 1 h, we assumed that composition of plasma
membrane was not disturbed.
Previously we have reported that pVEC–avidin complex is
mostly internalized in an ATP-dependent manner and inhibition
of clathrin-dependent endocytosis only slightly decreased the
uptake. The internalization of pVEC–avidin complex was also
remarkably decreased when cholesterol was depleted from
cellular membranes [5]. This indicates, together with present
data, that different uptake pathways may be used for different
CPPs. Also, different pathways may exist, depending on
whether the cargo is attached to the peptide or not.
In conclusion, the N-terminal hydrophobic stretch is
crucial for efficient cellular uptake of pVEC. Substitution of
the hydrophobic N-terminal amino acids to Ala significantly
decreased the cellular uptake. Our results further revealed
the presence of an endocytotic component in the uptake of
pVEC.Acknowledgements
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